TherapeuticsMD, Inc. (TXMD) Form 10-Q Quarterly Reports
TherapeuticsMD, Inc. (TXMD) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: TXMD
CIK: 25743
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: NV
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Carr, Riggs & Ingram LLC
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerBrent Leslie
Audit LocationPalm Beach Gardens, Florida, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 10-Q | 2026-08-11 | 2026-06-30 | QUARTERLY REPORT | 0001213900-26-087768 | View SEC Doc Filr Page |
| 8-K | 2026-08-11 | 2026-08-11 | CURRENT REPORT | 0001213900-26-087756 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-05 | — | SCHEDULE 13G/A Filing | 0001957912-26-000027 | View SEC Doc Filr Page |
| 10-Q | 2026-05-12 | 2026-03-31 | QUARTERLY REPORT | 0001213900-26-055081 | View SEC Doc Filr Page |
| 8-K | 2026-05-12 | 2026-05-02 | CURRENT REPORT | 0001213900-26-055070 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-04-06 | — | SCHEDULE 13G Filing | 0001493152-26-015371 | View SEC Doc Filr Page |
| 10-K/A | 2026-04-01 | 2025-12-31 | ANNUAL REPORT | 0001213900-26-037918 | View SEC Doc Filr Page |
| NT 10-K | 2026-04-01 | 2025-12-31 | NOTIFICATION OF LATE FILING | 0001213900-26-037914 | View SEC Doc Filr Page |
| 8-K | 2026-03-30 | 2026-03-30 | CURRENT REPORT | 0001213900-26-036519 | View SEC Doc Filr Page |
| 10-K | 2026-03-30 | 2025-12-31 | ANNUAL REPORT | 0001213900-26-036515 | View SEC Doc Filr Page |
| 8-K | 2026-01-21 | 2026-01-15 | CURRENT REPORT | 0001213900-26-005779 | View SEC Doc Filr Page |
| 4 | 2025-12-29 | 2025-12-23 | 4 Filing | 0000905148-25-004488 | View SEC Doc Filr Page |
| 8-K | 2025-12-16 | 2025-12-15 | CURRENT REPORT | 0001213900-25-122240 | View SEC Doc Filr Page |
| 8-K | 2025-11-13 | 2025-11-12 | CURRENT REPORT | 0001213900-25-109479 | View SEC Doc Filr Page |
| 10-Q | 2025-11-12 | 2025-09-30 | QUARTERLY REPORT | 0001213900-25-109381 | View SEC Doc Filr Page |
| 4 | 2025-11-05 | 2025-11-03 | 4 Filing | 0000905148-25-003785 | View SEC Doc Filr Page |
| 4 | 2025-11-05 | 2025-11-03 | 4 Filing | 0000905148-25-003784 | View SEC Doc Filr Page |
| 4 | 2025-11-05 | 2025-11-03 | 4 Filing | 0000905148-25-003783 | View SEC Doc Filr Page |
| 4 | 2025-11-05 | 2025-11-03 | 4 Filing | 0000905148-25-003782 | View SEC Doc Filr Page |
| ARS | 2025-11-03 | 2024-12-31 | ARS | 0001213900-25-105185 | View SEC Doc Filr Page |
| DEFA14A | 2025-11-03 | — | PROXY STATEMENT | 0001213900-25-105184 | View SEC Doc Filr Page |
| DEF 14A | 2025-11-03 | 2025-12-15 | PROXY STATEMENT | 0001213900-25-105183 | View SEC Doc Filr Page |
| PRE 14A | 2025-10-24 | 2025-10-24 | PROXY STATEMENT | 0001213900-25-102166 | View SEC Doc Filr Page |
| 10-Q | 2025-08-12 | 2025-06-30 | QUARTERLY REPORT | 0001213900-25-075003 | View SEC Doc Filr Page |
| 8-K | 2025-08-12 | 2025-08-12 | CURRENT REPORT | 0001213900-25-074975 | View SEC Doc Filr Page |